Her2-Low Breast Cancer

What HER2-Low Breast Cancer Means

HER2-low breast cancer is a subtype of breast cancer where the cancer cells have a small amount of a protein called HER2 on their surface. Unlike HER2-positive breast cancers, these cells do not have extra copies of the HER2 gene, which means they produce less HER2 protein. HER2 is a protein that can help cancer cells grow, so its presence or absence helps doctors classify breast cancers into different groups.

Why HER2-Low Breast Cancer Matters

For many years, HER2-low breast cancers were treated like HER2-negative cancers because the amount of HER2 protein was too low for traditional HER2-targeted drugs to work. However, newer targeted therapies have been developed that can effectively treat HER2-low breast cancer. This has expanded treatment options for patients with this subtype, especially for cancers that cannot be removed by surgery or have spread to other parts of the body.

What Patients Might See or Hear

Patients may encounter the term HER2-low breast cancer in medical reports, treatment discussions, or educational materials. They might also hear about specific drugs like Enhertu (fam-trastuzumab deruxtecan), which is a targeted therapy approved for HER2-low breast cancer. This drug combines an antibody that attaches to HER2 proteins with chemotherapy to kill cancer cells. Patients may be informed about treatment schedules, possible side effects such as nausea or tiredness, and the importance of regular monitoring during therapy.

Where the Term Might Appear

HER2-low breast cancer may be mentioned in pathology reports, treatment plans, clinical trial information, or drug guides. It is part of the molecular subtype classification of breast cancer, which helps doctors decide on the best treatment approach. Understanding this term in the context of a patient’s full medical information is important.

What HER2-Low Does Not Automatically Mean

Having HER2-low breast cancer does not mean the cancer is the same as HER2-positive breast cancer or that all HER2-targeted treatments will be effective. It also does not guarantee a specific outcome or response to treatment. The term describes a characteristic of the cancer cells but must be considered alongside other factors like hormone receptor status and overall health.

How to Use This Information

HER2-low breast cancer is a helpful classification for guiding treatment but is not a diagnosis or treatment recommendation by itself. Patients and caregivers should ask their healthcare team what HER2-low means for their individual case, what treatment options are available, and what to expect during care. This helps ensure decisions are personalized and based on the full medical picture.

Safety and Next Steps

This information is educational and does not replace medical advice. If HER2-low breast cancer appears in your medical records or discussions, the best next step is to talk with your care team to understand how it applies to your situation. They can explain what tests were done, what treatments might be appropriate, and how this classification fits into your overall care plan.